Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Zanatta

Showing results (51-60 of 98) with videos related to

Pageof 10
Sort By:
Pharmaceuticals (Basel, Switzerland)|August 26, 2022
Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Viewer or Actor? To Treat or Not to Treat?Barbara Ruaro, Riccardo Pozzan, Paola Confalonieri, et al.
Expert Review of Clinical Immunology|October 20, 2020
The power of the EUSTAR cohort: key findings to date and implications for management of systemic sclerosis patientsFrancesco Benvenuti, Elisabetta Zanatta, Jérôme Avouac, et al.
Clinical and Experimental Rheumatology|August 5, 2022
New onset and flare of rheumatic diseases following COVID-19 vaccination are mild and respond well to treatment: 9-month follow-up data from a single centre cohortMichela Gasparotto, Sara Bindoli, Roberto Padoan, et al.
Frontiers in Immunology|November 3, 2025
Patients with anti-SAE+ dermatomyositis display refractory and difficult-to-treat skin manifestations: case series from two Italian cohorts and review of literatureRoberto Depascale, Anna Ghirardello, Elisabetta Zanatta, et al.
Journal of Autoimmunity|May 24, 2024
Circulating extracellular vesicles and small non-coding RNAs cargo in idiopathic inflammatory myopathies reveal differences across myositis subsetsChiara Franco, Alessandra Giannella, Michela Gasparotto, et al.
Clinical and Experimental Rheumatology|December 3, 2024
Human epididymitis protein 4 as a biomarker of interstitial lung disease in patients with idiopathic inflammatory myopathiesElisabetta Zanatta, Beatrice Moccaldi, Andrea Martini, et al.
Rheumatology (Oxford, England)|May 16, 2020
Safety and efficacy of rituximab biosimilar (CT-P10) in systemic sclerosis: an Italian multicentre studyCorrado Campochiaro, Giacomo De Luca, Maria Grazia Lazzaroni, et al.
Arthritis Research & Therapy|October 29, 2020
Health Assessment Questionnaire-Disability Index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis: an analysis from the EUSTAR databaseYannick Allanore, Sylvie Bozzi, Augustin Terlinden, et al.
Autoimmunity Reviews|December 16, 2019
Outcomes of limited cutaneous systemic sclerosis patients: Results on more than 12,000 patients from the EUSTAR databaseCamelia Frantz, Dorte Huscher, Jérôme Avouac, et al.
Frontiers in Medicine|April 5, 2021
The PREdictor of MAlnutrition in Systemic Sclerosis (PREMASS) Score: A Combined Index to Predict 12 Months Onset of Malnutrition in Systemic SclerosisGianluca Bagnato, Erika Pigatto, Alessandra Bitto, et al.
Pageof 10

Showing results (51-60 of 98) with videos related to

Sort By:
Pageof 10
Pharmaceuticals (Basel, Switzerland)|August 26, 2022
Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Viewer or Actor? To Treat or Not to Treat?Barbara Ruaro, Riccardo Pozzan, Paola Confalonieri, et al.
Expert Review of Clinical Immunology|October 20, 2020
The power of the EUSTAR cohort: key findings to date and implications for management of systemic sclerosis patientsFrancesco Benvenuti, Elisabetta Zanatta, Jérôme Avouac, et al.
Clinical and Experimental Rheumatology|August 5, 2022
New onset and flare of rheumatic diseases following COVID-19 vaccination are mild and respond well to treatment: 9-month follow-up data from a single centre cohortMichela Gasparotto, Sara Bindoli, Roberto Padoan, et al.
Frontiers in Immunology|November 3, 2025
Patients with anti-SAE+ dermatomyositis display refractory and difficult-to-treat skin manifestations: case series from two Italian cohorts and review of literatureRoberto Depascale, Anna Ghirardello, Elisabetta Zanatta, et al.
Journal of Autoimmunity|May 24, 2024
Circulating extracellular vesicles and small non-coding RNAs cargo in idiopathic inflammatory myopathies reveal differences across myositis subsetsChiara Franco, Alessandra Giannella, Michela Gasparotto, et al.
Clinical and Experimental Rheumatology|December 3, 2024
Human epididymitis protein 4 as a biomarker of interstitial lung disease in patients with idiopathic inflammatory myopathiesElisabetta Zanatta, Beatrice Moccaldi, Andrea Martini, et al.
Rheumatology (Oxford, England)|May 16, 2020
Safety and efficacy of rituximab biosimilar (CT-P10) in systemic sclerosis: an Italian multicentre studyCorrado Campochiaro, Giacomo De Luca, Maria Grazia Lazzaroni, et al.
Arthritis Research & Therapy|October 29, 2020
Health Assessment Questionnaire-Disability Index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis: an analysis from the EUSTAR databaseYannick Allanore, Sylvie Bozzi, Augustin Terlinden, et al.
Autoimmunity Reviews|December 16, 2019
Outcomes of limited cutaneous systemic sclerosis patients: Results on more than 12,000 patients from the EUSTAR databaseCamelia Frantz, Dorte Huscher, Jérôme Avouac, et al.
Frontiers in Medicine|April 5, 2021
The PREdictor of MAlnutrition in Systemic Sclerosis (PREMASS) Score: A Combined Index to Predict 12 Months Onset of Malnutrition in Systemic SclerosisGianluca Bagnato, Erika Pigatto, Alessandra Bitto, et al.
Pageof 10